Quantitative assessment of lung density changes after 3-D radiotherapy for breast cancer

被引:19
作者
Blom-Goldman, Ulla
Svane, Gunilla
Wennberg, Berit
Lidestahl, Anders
Lind, Pehr A. R. M.
机构
[1] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Radiol, Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Hosp Phys, Stockholm, Sweden
[4] Karolinska Inst, S-10401 Stockholm, Sweden
关键词
D O I
10.1080/02841860600949586
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Our aim was to reduce the rates of clinical and radiological pneumonitis in local-regional radiotherapy (RT) for breast cancer compared to a previous treatment series by applying a pre-planned lung dose volume constraint. 3-D dose planning was performed in 66 women with the aim of not exceeding an ipsilateral V20 of 30%. The patients were followed for short-term signs/symptoms of post-RT pneumonitis and radiological changes on chest CT 4 months after RT. Radiological abnormalities were scored with a CT adapted modification of a semi-quantitative classification system originally proposed by Arriagada which accounts for severity and affected lung regions. The abnormal subvolumes were contoured and the mean doses were calculated. Three cases of mild and one case of moderate symptomatic pneumonitis were diagnosed. The mean V20 was higher in symptomatic than in unaffected patients, 29% vs. 24% (p=0.04). Mild/moderate radiological changes were frequently observed on CT in regions with average doses > 30 Gy. According to multivariate modeling, a trend for association was found between the studied dosimetric factors V13, V20, V30 and mean lung dose, and moderate-severe changes on CT but not with patient specific covariates, e.g. chemotherapy or tamoxifen exposure. 3-D planned local-regional RT with a preplanned lung dose volume constraint of V20 < 30% resulted in few cases of moderate symptomatic pneumonitis. Mild/moderate radiological changes were still detectable on CT in subvolumes receiving doses > 30 Gy. Longterm follow-up for evaluation of possible late morbidity is warranted.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 24 条
[1]  
Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0
[2]   LIMITED SMALL CELL LUNG-CANCER TREATED BY COMBINED RADIOTHERAPY AND CHEMOTHERAPY - EVALUATION OF A GRADING SYSTEM OF LUNG FIBROSIS [J].
ARRIAGADA, R ;
DEGUEVARA, JCL ;
MOURIESSE, H ;
HANZEN, C ;
COUANET, D ;
RUFFIE, P ;
BALDEYROU, P ;
DEWAR, J ;
LUSINCHI, A ;
MARTIN, M ;
LECHEVALIER, T .
RADIOTHERAPY AND ONCOLOGY, 1989, 14 (01) :1-8
[3]   Radiotherapy-related lung fibrosis enhanced by tamoxifen [J].
Bentzen, SM ;
Skoczylas, JZ ;
Overgaard, M ;
Overgaard, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (13) :918-922
[4]  
BOERSMA L, 1995, LUNG FUNCTION RADIOT, P203
[5]  
*DCTD NCI DHHS, CANC THER EV PROGR C
[6]   Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials [J].
Early Breast Cancer Trialists' Collaborative Group .
LANCET, 2000, 355 (9217) :1757-1770
[7]  
GAGLIARDI G, 1998, MODELING HEART LUNG, P61
[8]   Radiological pulmonary findings after breast cancer irradiation:: A prospective study [J].
Järvenpää, R ;
Holli, K ;
Pitkänen, M ;
Hyödynmaa, S ;
Rajala, J ;
Lahtela, L ;
Ojala, A .
ACTA ONCOLOGICA, 2006, 45 (01) :16-22
[9]   Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients [J].
Johansson, S ;
Bjermer, L ;
Franzen, L ;
Henriksson, R .
RADIOTHERAPY AND ONCOLOGY, 1998, 49 (01) :41-47
[10]   Clinical relevance of pulmonary toxicity in adjuvant breast cancer irradiation [J].
Lind, P .
ACTA ONCOLOGICA, 2006, 45 (01) :13-15